Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Retained Earnings: 2010-2025

Historic Retained Earnings for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Sep 2025 value amounting to -$1.7 billion.

  • Ironwood Pharmaceuticals' Retained Earnings rose 1.68% to -$1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 billion, marking a year-over-year increase of 1.68%. This contributed to the annual value of -$1.7 billion for FY2024, which is 0.05% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Retained Earnings stood at -$1.7 billion for Q3 2025, which was up 2.34% from -$1.7 billion recorded in Q2 2025.
  • Ironwood Pharmaceuticals' 5-year Retained Earnings high stood at -$650.7 million for Q1 2023, and its period low was -$1.7 billion during Q1 2025.
  • For the 3-year period, Ironwood Pharmaceuticals' Retained Earnings averaged around -$1.6 billion, with its median value being -$1.7 billion (2024).
  • In the last 5 years, Ironwood Pharmaceuticals' Retained Earnings spiked by 41.62% in 2022 and then crashed by 161.70% in 2024.
  • Quarterly analysis of 5 years shows Ironwood Pharmaceuticals' Retained Earnings stood at -$937.6 million in 2021, then grew by 25.73% to -$696.4 million in 2022, then tumbled by 143.92% to -$1.7 billion in 2023, then climbed by 0.05% to -$1.7 billion in 2024, then grew by 1.68% to -$1.7 billion in 2025.
  • Its Retained Earnings stands at -$1.7 billion for Q3 2025, versus -$1.7 billion for Q2 2025 and -$1.7 billion for Q1 2025.